These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24325392)

  • 61. Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.
    Duraffour S; Andrei G; Topalis D; Krečmerová M; Crance JM; Garin D; Snoeck R
    J Virol; 2012 Jul; 86(13):7310-25. PubMed ID: 22532673
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In Vitro and In Vivo Evaluation of Cidofovir as a Topical Ophthalmic Antiviral for Ocular Canine Herpesvirus-1 Infections in Dogs.
    Ledbetter EC; Spertus CB; Pennington MR; Van de Walle GR; Judd BE; Mohammed HO
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):642-9. PubMed ID: 26418618
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cidofovir administered with radiation displays an antiangiogenic effect mediated by E6 inhibition and subsequent TP53-dependent VEGF repression in HPV18+ cell lines.
    Amine A; Vozenin-Brotons MC; Abdulkarim B; Violot D; Aubel C; Bourhis J
    Radiat Res; 2006 Oct; 166(4):600-10. PubMed ID: 17007547
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance.
    Chou S; Ercolani RJ; Lanier ER
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3845-8. PubMed ID: 27044553
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
    Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
    Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
    Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
    Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
    Quenelle DC; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Kern ER
    Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cidofovir on HHV-8 in BCBL-1 cells.
    Pica F; Serafino A; Garaci E; Volpi A
    Antivir Ther; 2004 Oct; 9(5):823-5. PubMed ID: 15535421
    [No Abstract]   [Full Text] [Related]  

  • 69. Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.
    Aldern KA; Ciesla SL; Winegarden KL; Hostetler KY
    Mol Pharmacol; 2003 Mar; 63(3):678-81. PubMed ID: 12606777
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation.
    Xiong X; Smith JL; Chen MS
    Antimicrob Agents Chemother; 1997 Mar; 41(3):594-9. PubMed ID: 9055999
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alpha interferon augments cidofovir's antiviral and antiproliferative activities.
    Johnson JA; Gangemi JD
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2022-6. PubMed ID: 12760891
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
    Donne AJ; Hampson L; He XT; Day PJ; Salway F; Rothera MP; Homer JJ; Hampson IN
    Antivir Ther; 2009; 14(7):939-52. PubMed ID: 19918098
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potent inhibition of hemangiosarcoma development in mice by cidofovir.
    Liekens S; Verbeken E; De Clercq E; Neyts J
    Int J Cancer; 2001 Apr; 92(2):161-7. PubMed ID: 11291040
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytomegalovirus mutants resistant to ganciclovir and cidofovir differ in susceptibilities to synguanol and its 6-ether and 6-thioether derivatives.
    Chou S; Komazin-Meredith G; Williams JD; Bowlin TL
    Antimicrob Agents Chemother; 2014; 58(3):1809-12. PubMed ID: 24379208
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 76. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Solution structure of a DNA duplex containing the potent anti-poxvirus agent cidofovir.
    Julien O; Beadle JR; Magee WC; Chatterjee S; Hostetler KY; Evans DH; Sykes BD
    J Am Chem Soc; 2011 Feb; 133(7):2264-74. PubMed ID: 21280608
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antiproliferative and antiviral mechanisms of ursolic acid and dexamethasone in cervical carcinoma cell lines.
    Yim EK; Lee MJ; Lee KH; Um SJ; Park JS
    Int J Gynecol Cancer; 2006; 16(6):2023-31. PubMed ID: 17177841
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of cidofovir on cell death and replication of feline herpesvirus-1 in cultured feline corneal epithelial cells.
    Sandmeyer LS; Keller CB; Bienzle D
    Am J Vet Res; 2005 Feb; 66(2):217-22. PubMed ID: 15757118
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro susceptibility of sea lion poxvirus to cidofovir.
    Nollens HH; Gulland FM; Jacobson ER; Hernandez JA; Klein PA; Walsh MT; Condit RC
    Antiviral Res; 2008 Oct; 80(1):77-80. PubMed ID: 18485494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.